Article
CMV promoter is inadequate for expression of mutant human RyR2 in transgenic rabbits.
Journal of pharmacological and toxicological methods - 1 Jan 2000
Wakula Paulina, Bisping Egbert, Kockskämper Jens, Post Heiner, Brauer Sabine, Deuter Marion, Oehlmann Ralph, Besenfelder Urban, Lai F Anthony, Brem Gottfried, Pieske Burkert
Abstract excerpt
INTRODUCTION: Fundamental differences in Ca²+ homeostasis between mice and larger mammals require the validation of the mechanisms of arrhythmogenesis before translation into human pathophysiology. The purpose of this study was to create transgenic rabbits that express defective human cardiac ryanodine receptor (hRyR2) with a mutation (R4497C) causing a clinically relevant arrhythmogenic syndrome. METHODS: The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
